Nicholas Investment Partners, LP Immuno Gen, Inc. Transaction History

Nicholas Investment Partners, LP

  • $900 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 07, 2024
SELL
$12.46 - $29.95 $23.9 Million - $57.5 Million
-1,918,889 Reduced 92.81%
148,672 $4.41 Million
Q3 2023

Nov 13, 2023
BUY
$14.09 - $19.87 $11.9 Million - $16.8 Million
843,434 Added 68.9%
2,067,561 $32.8 Million
Q2 2023

Aug 09, 2023
BUY
$3.75 - $20.05 $4.59 Million - $24.5 Million
1,224,127 New
1,224,127 $23.1 Million

Others Institutions Holding IMGN

# of Institutions
8
Shares Held
1.41M
Call Options Held
0
Put Options Held
0
View Full List

About ImmunoGen, Inc.

IMGN Quotes by TradingView
  • Ticker IMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 220,712,992
  • Description
  • ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...
More about IMGN
Track This Portfolio

Track Nicholas Investment Partners, LP Portfolio

Follow Nicholas Investment Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Investment Partners, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email